Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate? (DELPHI)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01737060 |
Recruitment Status :
Completed
First Posted : November 29, 2012
Last Update Posted : October 4, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Proximal Humeral Fractures, AO/OTA (2007) Group B2 and C2 | Device: Reverse total shoulder arthroplasty | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 124 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Clinical Investigation for Fractures of the Proximal Humerus in Elderly Patients. A Randomized Study of Two Surgical Treatments: Reverse Total Shoulder Arthroplasty Versus Angular Stable Device Philos |
Actual Study Start Date : | January 1, 2013 |
Actual Primary Completion Date : | August 1, 2017 |
Actual Study Completion Date : | September 1, 2022 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Angular stable plate Philos
Open Reduction and Osteofixation with Philos plate and TiCron cerclages
|
Device: Reverse total shoulder arthroplasty
Other Name: Delta Xtend shoulder proshesis |
Experimental: Reverse Total Shoulder Artroplasty
Intervention group
|
Device: Reverse total shoulder arthroplasty
Other Name: Delta Xtend shoulder proshesis |
- Constant Shoulder Score [ Time Frame: 5 years ]Follow-up will be at 3-6-12 months and 2-5 years.
- Oxford Shoulder score [ Time Frame: 5 years ]Follow-up will be at 3-6-12 months and 2-5 years.
- 15D Quality of Life score [ Time Frame: 5 years ]Follow-up will be at 3-6-12 months and 2-5 years.
- Health Economics [ Time Frame: 5 years ]Follow-up will be at 3-6-12 months and 2-5 years.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 65 Years to 85 Years (Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patient admitted in hospital with a displaced three- or four part proximal humerus fracture of OTA / AO group 11-B2 or 11-C2 (displaced fracture of extra-articular or articular, bifocal type). The subgroups -.1, -.2 and -.3 will be included for both B2 and C2 groups, provided severe displacement: This is defined as a mal-position of at least 45º of angular deviation in valgus or 30º in varus in true frontal projection, regardless of whether the fracture is impacted or not, or less than 50% contact between humeral head and the metaphyseal part of the shaft. The greater or lesser tubercle displaced at least 10 mm.
Exclusion Criteria:
Patient younger than 65 years or older than 85 years, previous history of injury or illness of the injured shoulder, injuries of other parts of the humerus or the contra-lateral upper extremity, alcohol- or drug abuse, dementia, neurological diseases, or severe cardiovascular or lung diseases that would contraindicate surgery. Patients have to understand the Norwegian language and be compliant to rehabilitation and follow-ups.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01737060
Norway | |
Oslo University Hospital | |
Oslo, Norway |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Tore Fjalestad, MD PhD Senior Consultant, Oslo University Hospital |
ClinicalTrials.gov Identifier: | NCT01737060 |
Other Study ID Numbers: |
RTSA s422 |
First Posted: | November 29, 2012 Key Record Dates |
Last Update Posted: | October 4, 2022 |
Last Verified: | October 2022 |
Reversed prosthesis, Philos, Severe displaced |
Fractures, Bone Humeral Fractures Shoulder Fractures |
Wounds and Injuries Arm Injuries Shoulder Injuries |